Search filters

List of works by Arlene A Forastiere

A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck: a trial of the Eastern Cooperative Oncology Group (E1303).

scientific article

Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid Cancer ⬇️

scientific article published on May 23, 2011

American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer

scientific article published on 10 July 2006

Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II study

scientific article published on 9 June 2008

Chemoradiation in the management of esophageal cancer

scientific article published on September 2007

Chemoradiotherapy for localized esophageal cancer: regimen selection and molecular mechanisms of radiosensitization

scientific article published on May 2007

Chemoradiotherapy vs. total laryngectomy for primary treatment of advanced laryngeal squamous cell carcinoma

scientific article

Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.

scientific article

Clinical Correlates of Promoter Hypermethylation of Four Target Genes in Head and Neck Cancer: A Cooperative Group Correlative Study ⬇️

scientific article published on February 26, 2013

Combined-modality therapy for esophageal cancer: are we making progress?

scientific article

Detection of tumor epidermal growth factor receptor pathway dependence by serum mass spectrometry in cancer patients

scientific article

Genetic variation in DNA-repair pathways and response to radiochemotherapy in esophageal adenocarcinoma: a retrospective cohort study of the Eastern Cooperative Oncology Group

scientific article

HPV-associated head and neck cancer: a virus-related cancer epidemic

scientific article

Impact of surgeon and hospital volume on short‐term outcomes and cost of oropharyngeal cancer surgical care ⬇️

scientific article published on April 1, 2011

Is open surgery for head and neck cancers truly declining?

scientific article

Long-Term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment Strategies to Preserve the Larynx in Patients With Locally Advanced Larynx Cancer ⬇️

scientific article published on November 26, 2012

Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck

scientific article

Modeling using baseline characteristics in a small multicenter clinical trial for Barrett's esophagus

scientific article

Multidisciplinary approaches in the management of advanced head and neck tumors: state of the art.

scientific article published on May 2004

Neck dissection followed by radiotherapy or chemoradiotherapy for small primary oropharynx carcinoma with cervical metastasis

scientific article

Organ preservation for cancer of the larynx: current indications and future directions

scientific article published on April 2004

Organ preservation trials for laryngeal cancer

scientific article

Organ preservation with chemoradiation in advanced laryngeal cancer: The problem of generalizing results from randomized controlled trials.

scientific article

Outcome of elderly patients with recurrent or metastatic head and neck cancer treated with cisplatin-based chemotherapy

scientific article

Patients and Physicians Can Discuss Costs of Cancer Treatment in the Clinic.

scientific article published on 26 May 2015

Phase II 2-arm trial of the proteasome inhibitor, PS-341 (bortezomib) in combination with irinotecan or PS-341 alone followed by the addition of irinotecan at time of progression in patients with locally recurrent or metastatic squamous cell carcino

scientific article published on 13 July 2012

Phase II evaluation of 96-hour paclitaxel infusion in advanced (recurrent or metastatic) squamous cell carcinoma of the head and neck (E3395): a trial of the Eastern Cooperative Oncology Group

scientific article

Phase II study of cetuximab in combination with cisplatin and radiation in unresectable, locally advanced head and neck squamous cell carcinoma: Eastern cooperative oncology group trial E3303.

scientific article

Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: an Eastern Cooperative Oncology Group study

scientific article

Phase III randomized, placebo-controlled trial of docetaxel with or without gefitinib in recurrent or metastatic head and neck cancer: an eastern cooperative oncology group trial

scientific article published on 4 March 2013

Predicting survival in head and neck squamous cell carcinoma from TP53 mutation.

scientific article

Prognostic and predictive factors in recurrent and/or metastatic head and neck squamous cell carcinoma: A review of the literature

scientific article published on 13 February 2019

Prognostic biomarkers in phase II trial of cetuximab-containing induction and chemoradiation in resectable HNSCC: Eastern cooperative oncology group E2303.

scientific article

Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group

scientific article

Reassessment of the role of induction chemotherapy for head and neck cancer

scientific article published on July 2006

Recurrence after neoadjuvant chemoradiation and surgery for esophageal cancer: does the pattern of recurrence differ for patients with complete response and those with partial or no response?

scientific article published on December 2009

Response assessment after induction chemotherapy for head and neck squamous cell carcinoma: From physical examination to modern imaging techniques and beyond.

scientific article published on 17 August 2017

Secondary chemoprevention of Barrett's esophagus with celecoxib: results of a randomized trial

scientific article (publication date: 4 April 2007)

TP53 mutations and survival in squamous-cell carcinoma of the head and neck.

scientific article

The Ligamp TP53 Assay for Detection of Minimal Residual Disease in Head and Neck Squamous Cell Carcinoma Surgical Margins

scientific article

Validation of brief symptom indexes among patients with recurrent or metastatic squamous cell carcinoma of the head and neck: A trial of the ECOG-ACRIN Cancer Research Group (E1302)

scientific article published on 10 October 2020

When is chemotherapy in head and neck squamous cell carcinoma not indicated?

scientific article published on 14 February 2014

Paulina is supported by:

About Paulina

Help